Basic concept of treatment for chronic heart failure:past, present and future
10.11958/20160304
- VernacularTitle:慢性心衰治疗的基本理念：过去、现在和未来
- Author:
Jun HUANG
- Publication Type:Journal Article
- Keywords:
heart failure;
renin-angiotensin system;
sympathetic nervous system;
ventricular remodeling;
Ivabradine;
LCZ696;
Qiliqiangxin capsule;
myocardial remodeling;
neuroendocrine blockade
- From:
Tianjin Medical Journal
2016;44(8):929-931
- CountryChina
- Language:Chinese
-
Abstract:
In the 70s of last century, the treatment of chronic heart failure (CHF) mainly uses inotropic drugs, diuretic and vasodilators, which can improve the hemodynamic condition and have no change in mortality in patients. Since the end of 1980s, excessive activation of the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system have demonstrated to play a key role in the pathophysiology of CHF. Blockade of these two systems can significantly reduce the mortality of CHF, which become a comerstone of the treatment of heart failure. Since 2010, three different types of drugs namely ivabradine, LCZ696 and a kind of traditional Chinese medicine have been shown confirmed the curative effects for heart failure, that means a new concept of CHF treatment, neurohormonal blockade/inducing and systematical regulation.
